126 related articles for article (PubMed ID: 22543082)
21. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
22. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
24. Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.
Hsieh WY; Chang TH; Chang HF; Chuang WH; Lu LC; Yang CW; Lin CS; Chang CC
PLoS One; 2019; 14(1):e0210656. PubMed ID: 30633770
[TBL] [Abstract][Full Text] [Related]
25. Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury.
Estrela GR; Wasinski F; Bacurau RF; Malheiros DM; Câmara NO; Araújo RC
Int Immunopharmacol; 2014 Sep; 22(1):115-9. PubMed ID: 24975837
[TBL] [Abstract][Full Text] [Related]
26. [Angiotensin II antagonist treatment as a contributory cause of acute renal failure].
Nielsen LR
Ugeskr Laeger; 2003 Mar; 165(13):1368-9. PubMed ID: 12703286
[TBL] [Abstract][Full Text] [Related]
27. Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI.
Zhang J; Rudemiller NP; Patel MB; Wei Q; Karlovich NS; Jeffs AD; Wu M; Sparks MA; Privratsky JR; Herrera M; Gurley SB; Nedospasov SA; Crowley SD
J Am Soc Nephrol; 2016 Aug; 27(8):2257-64. PubMed ID: 26744488
[TBL] [Abstract][Full Text] [Related]
28. [Renin-aldosterone and bone metabolism].
Ikeda K
Clin Calcium; 2014 Jun; 24(6):885-91. PubMed ID: 24870840
[TBL] [Abstract][Full Text] [Related]
29. Low-dose angiotensin AT
Esmaeeli A; Ebrahimi F; Tanha K; Assadi M; Seyedabadi M
Pharmacol Rep; 2020 Dec; 72(6):1676-1684. PubMed ID: 33090352
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice.
Tanino A; Okura T; Nagao T; Kukida M; Pei Z; Enomoto D; Miyoshi K; Okamura H; Higaki J
Clin Sci (Lond); 2016 Oct; 130(19):1727-39. PubMed ID: 27413021
[TBL] [Abstract][Full Text] [Related]
31. Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
Mishina M; Watanabe T
J Vet Med Sci; 2008 May; 70(5):455-60. PubMed ID: 18525166
[TBL] [Abstract][Full Text] [Related]
32. Association between renal injury and reduced interleukin-15 and interleukin-15 receptor levels in acute kidney injury.
Eini H; Tejman-Yarden N; Lewis EC; Chaimovitz C; Zlotnik M; Douvdevani A
J Interferon Cytokine Res; 2010 Jan; 30(1):1-8. PubMed ID: 19958157
[TBL] [Abstract][Full Text] [Related]
33. New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage.
Takai S; Jin D; Miyazaki M
J Pharmacol Sci; 2010; 113(4):301-9. PubMed ID: 20675958
[TBL] [Abstract][Full Text] [Related]
34. Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor.
Kim H; Lee H; Lee G; Jang H; Kim SS; Yoon H; Kang GH; Hwang DS; Kim SK; Chung HS; Bae H
Kidney Int; 2015 Sep; 88(3):550-9. PubMed ID: 25993317
[TBL] [Abstract][Full Text] [Related]
35. Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors.
Zhang MZ; Yao B; Cheng HF; Wang SW; Inagami T; Harris RC
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16045-50. PubMed ID: 17043228
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic study of cisplatin-induced nephrotoxicity.
Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
[TBL] [Abstract][Full Text] [Related]
37. [LIGHT/ TNFSF14 alleviates cisplatin-induced acute kidney injury in mice and its mechanism].
Yang Y; Zhong Y; Meng L; Xie P; Xu G; Peng K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):897-902. PubMed ID: 31814566
[TBL] [Abstract][Full Text] [Related]
38. Prolonged inhibition of angiotensin II attenuates glycerol-induced acute renal failure.
Abdulkader RC; Yuki MM; Paiva AC; Marcondes M
Braz J Med Biol Res; 1988; 21(2):233-9. PubMed ID: 3203159
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study.
McSweeney KR; Gadanec LK; Kubatka P; Caprnda M; Gaspar L; Prosecky R; Delev D; Kruzliak P; Apostolopoulos V; Zulli A
Mol Cell Biochem; 2023 Dec; 478(12):2907-2916. PubMed ID: 37004639
[TBL] [Abstract][Full Text] [Related]
40. Early response as shown by enhancement of transglutaminase 1 expression after cisplatin-induced acute kidney injury.
Furukawa K; Yamane M; Tatsukawa H; Hitomi K
Arch Biochem Biophys; 2015 Nov; 586():27-32. PubMed ID: 26427353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
